MoneyWorks4Me

Medicamen Biotech - Quaterly Results

08 Aug 2023 Evaluate
A fair growth of 22.41% in the revenue at Rs. 405.03 millions was reported in the June 2023 quarter as compared to Rs. 330.88 millions during year-ago period.Net profit stood at Rs. 44.18  millions  compared to Rs. 35.86 millions in the corresponding previous quarter,high by 23.20%.Operating profit surged to 77.90 millions from the corresponding previous quarter of 66.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 405.03 330.88 22.41 405.03 330.88 22.41 1378.84 1154.45 19.44
Other Income 3.79 9.62 -60.60 3.79 9.62 -60.60 24.62 17.20 43.14
PBIDT 77.90 66.19 17.69 77.90 66.19 17.69 266.09 252.74 5.28
Interest 9.56 7.67 24.64 9.56 7.67 24.64 29.23 14.01 108.64
PBDT 68.34 58.52 16.78 68.34 58.52 16.78 236.86 238.73 -0.78
Depreciation 16.80 15.27 10.02 16.80 15.27 10.02 63.54 57.71 10.10
PBT 51.54 43.25 19.17 51.54 43.25 19.17 173.32 181.02 -4.25
TAX 7.36 7.39 -0.41 7.36 7.39 -0.41 23.31 31.97 -27.09
Deferred Tax -5.09 -2.39 112.97 -5.09 -2.39 112.97 -13.69 -7.80 75.51
PAT 44.18 35.86 23.20 44.18 35.86 23.20 150.01 149.05 0.64
Equity 126.51 122.17 3.55 126.51 122.17 3.55 126.51 122.17 3.55
PBIDTM(%) 19.23 20.00 -3.85 19.23 20.00 -3.85 19.30 21.89 -11.85
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..